PMC:7408073 / 57134-57300 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2059","span":{"begin":56,"end":59},"obj":"Gene"},{"id":"2077","span":{"begin":69,"end":74},"obj":"Chemical"},{"id":"2078","span":{"begin":121,"end":130},"obj":"Chemical"}],"attributes":[{"id":"A2059","pred":"tao:has_database_id","subj":"2059","obj":"Gene:4295"},{"id":"A2078","pred":"tao:has_database_id","subj":"2078","obj":"MESH:D004220"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Another study evaluated the inhibitory activity of both MLN-4760 and DX600 (either the linear conformational form or the disulfide bridged cyclic variant) inhibitors."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T707","span":{"begin":39,"end":47},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Another study evaluated the inhibitory activity of both MLN-4760 and DX600 (either the linear conformational form or the disulfide bridged cyclic variant) inhibitors."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T41578","span":{"begin":121,"end":130},"obj":"Chemical"},{"id":"T100","span":{"begin":155,"end":165},"obj":"Chemical"}],"attributes":[{"id":"A68488","pred":"chebi_id","subj":"T41578","obj":"http://purl.obolibrary.org/obo/CHEBI_48343"},{"id":"A45334","pred":"chebi_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"Another study evaluated the inhibitory activity of both MLN-4760 and DX600 (either the linear conformational form or the disulfide bridged cyclic variant) inhibitors."}

{"project":"LitCovid-sentences","denotations":[{"id":"T276","span":{"begin":0,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Another study evaluated the inhibitory activity of both MLN-4760 and DX600 (either the linear conformational form or the disulfide bridged cyclic variant) inhibitors."}